Notice 20 May 2025 regulatory compliance, controlled substances, drug enforcement administration, business applications, patheon api inc

📦Patheon API Inc. Applies for Controlled Substances Import Registration

Patheon API Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 25 Apr 2025 healthcare compliance, controlled substances, drug enforcement administration, illinois, medical licensing, state regulation

⚖️Implications of DEA Registration Revocation for Medical Practitioners

The Drug Enforcement Administration (DEA) issued an order revoking the registration of Syed Warsi, M.D., due to the suspension of his medical license in Illinois. This decision, based on the authority of federal and state laws, emphasizes the critical need for practitioners to maintain valid licenses to handle controlled substances, impacting compliance within the healthcare sector.

Learn More
Notice 16 Apr 2025 regulatory compliance, new york, dea, controlled substances, drug enforcement administration, medical practice

⚖️DEA Revokes Registration of David Israel, M.D. for Misconduct

The Drug Enforcement Administration issued an order revoking David Israel, M.D.’s DEA registration due to unlawful prescription practices outside the usual course of professional practice. Allegations include issuing prescriptions for controlled substances without legitimate medical purpose, leading to significant legal and operational implications for the medical professional.

Learn More
Notice 16 Apr 2025 compliance, healthcare, regulation, controlled substances, oklahoma, drug enforcement administration, medical licensing

⚖️Revocation of Medical Registration

The Drug Enforcement Administration issued an Order to Show Cause for the revocation of Dr. Henry-Norbert O. Ndekwe's registration due to his lack of authority to handle controlled substances in Oklahoma. The document outlines the legal processes regarding the revocation and highlights the implications for healthcare practitioners and businesses in the industry.

Learn More
Notice 27 Mar 2025 texas, drug enforcement administration, healthcare regulation, medical compliance, dea registration

⚖️DEA Revokes Registration of Texas Practitioner

The Drug Enforcement Administration has revoked the DEA registration of Willard J. Davis, D.O., due to his lack of authority to handle controlled substances in Texas following the suspension of his medical license. The decision emphasizes the need for practitioners to possess valid licenses to maintain DEA registration.

Learn More
Notice 20 Mar 2025 regulatory compliance, controlled substances, drug enforcement administration, mississippi, medical licensing

⚖️DEA Revokes Registration of Hazem Barmada, M.D. for Compliance Issues

The Drug Enforcement Administration has revoked Hazem Barmada, M.D.'s certification due to his lack of licensure in Mississippi, impacting his ability to handle controlled substances. This decision underscores the necessity for medical practitioners to maintain state compliance to retain DEA registrations and operate legally.

Learn More
Notice 26 Feb 2025 regulatory compliance, import, clinical trials, controlled substances, business registration, drug enforcement administration, sharp clinical services

💊Notice of Importer Application for Controlled Substances

Sharp Clinical Services, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 21 Feb 2025 compliance, healthcare, regulation, vermont, licensing, drug enforcement administration, new hampshire

🚫Revocation of DEA Registrations

The Drug Enforcement Administration issued orders to revoke Jason Weakley R.N., A.P.R.N.'s DEA registrations due to expired state licenses in Vermont and New Hampshire. The findings indicate a lack of authority to handle controlled substances, underscoring the critical need for compliance with state laws in the healthcare sector.

Learn More
Notice 14 Feb 2025 public interest, healthcare regulations, registration revocation, drug enforcement administration, professional compliance, dental practices

🚫DEA Revocation of Registration

The decision by the Drug Enforcement Administration to revoke Robert L. Carter, D.D.S.'s DEA registration for falsifying applications raises critical compliance issues for healthcare providers. The ruling highlights the stringent standards regulating controlled substance handling and underscores the importance of maintaining integrity in application processes to ensure safeguarding public interest.

Learn More
Notice 13 Feb 2025 regulatory compliance, pharmaceutical industry, controlled substances, drug enforcement administration, mylan inc.

💊Mylan Inc. Seeks Registration for Controlled Substance Importing

Mylan Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More